智通财经网·2025-11-28 14:54Core Viewpoint - China National Pharmaceutical Group (国药控股) announced the resignation of key board members and the appointment of new directors, indicating a significant leadership change within the company [1] Group 1: Resignations - Mr. Zhao Bingxiang has resigned from multiple positions including non-executive director, chairman of the board, and various committee roles effective from November 28, 2025 [1] - Ms. Feng Rongli has also resigned from her roles as non-executive director and committee member effective from the same date [1] Group 2: Appointments - The board has proposed the appointment of Mr. Jin Bin and Ms. Li Ying as non-executive directors [1] - Mr. Jin Bin is set to be elected as chairman and authorized representative of the board, pending shareholder approval at the upcoming general meeting [1] - Mr. Jin will also take on roles as chairman of the nomination committee, strategic and investment committee, and member of the legal compliance and environmental, social, and governance committee, subject to shareholder approval [1]